Healthcare Realty Trust Incorpo (HR) Stock Price & How to Invest

Healthcare Realty Trust is a real estate investment trust focused on outpatient medical facilities, primarily medical office buildings leased to health systems, physician groups, and related healthcare tenants, with properties concentrated on or near acute-care hospital campuses. The company became the largest dedicated owner of medical office real estate after its 2022 combination with Healthcare Trust of America, and it earns rent from a diversified base of healthcare providers whose demand tends to be less cyclical than other property types.

The investment picture centers on funds from operations (FFO), occupancy, and the balance sheet rather than rapid growth. Management has been raising occupancy toward the low-90s percent range, growing same-store cash net operating income, and selling assets to pay down debt, while the dividend (a defining feature of most REITs) provides the bulk of the total-return case. Interest rates matter a great deal here: higher-for-longer rates raise financing costs and pressure REIT valuations, so HR is generally viewed through an income-and-stability lens.

As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt can also dilute near-term earnings power. Any broader weakness in commercial real estate values could weigh on the shares.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Healthcare Realty Trust Incorpo's investor relations page or your broker.

• Market cap: ~$7.1B
• Revenue (TTM): ~$1.2B
• Normalized FFO/share (Q1 2026): ~$0.41
• FY2026 normalized FFO guidance: ~$1.59-$1.65
• Dividend yield: ~4.7%
• Net debt / adjusted EBITDA: ~5.4x

REITs are usually valued on FFO per share and dividend yield rather than standard price-to-earnings, because large non-cash depreciation charges understate GAAP earnings. HR trades as an income vehicle, with a quarterly dividend near $0.24 per share and a yield in the mid-4-percent range as of mid-2026. Figures are approximate and drawn from recent results and guidance.

There are three common ways to get HR exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so HR sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where HR fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

HR is a yield-focused healthcare REIT whose story hinges on lifting occupancy, growing same-store cash flow, and paying down debt after its 2022 Healthcare Trust of America merger.

Whether HR is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is HR a buy?, and where the stock could go from here in the HR stock forecast.

For income investors, whether HR pays a dividend and how the payout looks is covered in does HR pay a dividend?